Priorities and Threats of Antibiotic Resistance
DOI:
https://doi.org/10.14738/bjhmr.102.14293Keywords:
AMR, antibiotics, ASM, DUSP6, GO775Abstract
The history of the antibiotics would now be too long to be reported in detail. However, since the middle of the last century, after a first attempt made by sulfonamides, before, during and after the Second World War, it was precisely their discoverers who laid the foundations for the modalities of a therapeutic treatment which undoubtedly radically changed the life expectancy of most of the known infectious diseases, especially as regards the world of bacteria. Therefore, we report their formulas together with the great scholars who discovered them.
References
Tarro G. Nosocomial infections and antibiotic resistance. Messina Medica 2.0. August 17, 2020.
Tarro G and Altucci P. Medicine and Perspectives of life. MEDIC vol 24(2):51-57, 2016.
Altucci P and Tarro G. Role of etiopathogenesis in Internal Medicine. Il Policlinico Sez. Med. vol 121: 61-81, 2014.
Smith PA, Koehler MFT, Girgis HS and et al. Optimized arylomycins are a new class of Gram – negative antibiotics. NATURE vol 561: 189-194, September 13, 2018.
Editorials. Progress on antibiotic resistance. NATURE vol 562: 307-308, October 18, 2018.
Li Guanjin, Yu Mingcan, Lee Won-Woo, Tsang Michael, Krishnan Eswar, Weyand M C, Goronzy J J. Decline in miR-181 an expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nature Medicine. 18, 1518-1524, 2012
Tarro G and Altucci P. Mycoplasmas and mycoplasmosis: 20 years later. Il Policlinico Sez. Prot. vol 121: 229-245, 2014 Tarro, G. (2023). Priorities and Threats of Antibiotic Resistance. British Journal of Healthcare and Medical Research, Vol - 10(2). 141-146. Figures Penicilli n Sulfanilami de Streptomyc Cephalospor in in Chlorampheni Tetracycli col ne Erythromyc Nalidixic in acid
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Giulio Tarro

This work is licensed under a Creative Commons Attribution 4.0 International License.